Aug. 08, 2019News & Opinions
In a transaction valued at around $2.4 billion including net debt, US small molecule innovator and API specialist Cambrex has agreed to be acquired by an affiliate of the Permira private equity funds.
Sep. 06, 2018News & Opinions
Evonik is selling its Jayhawk site in Galena, Kansas, USA, as it takes the next step to focus on specialty chemicals. The German group has agreed a share deal under which funds advised by investment firm Permira will acquire the site along ...
Apr. 03, 2016Topics
Is there a proven management recipe for turning a chemical industry spinoff into a success story? Camelot Management Consultants analyzed the history and performance of 20 such spinoffs. Despite individual differences between these firms, ...
Oct. 21, 2014News & Opinions
Specialty chemicals company Platform Specialty Products Corp has signed a "definitive agreement" to buy rival Arysta LifeScience for about $3.51 billion from an unnamed company backed by private equity investor Permira.
The latest information directly via newsletter.